The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
The University at Buffalo School of Medicine and Biomedical Sciences designates this enduring materials activity for a maximum of 22 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is designed to provide physicians preparing for the EMS board certification exam with an opportunity to take and review simulated test questions. The program contains over 1,100 practice items with explanations.
At the conclusion of this program the learner should be able to:
- Demonstrate an understanding of the potentially testable areas within the core content of EMS medicine.
- Analyze performance and identify areas where additional study may be helpful in exam preparation.
Software needed to complete the online program
Participants may use standard internet browsers to access the program at
Additional information about preferred software can be found after logging in.
The organization date for this CME program is June 1, 2017. The program release date will occur on about June 1, 2017. The termination data for the programs will be October 1, 2017.
In late September 2017, participants will receive an email with information on how to claim CME credit. All CME credit must be claimed by October 5, 2017.
The Accreditation Council for Continuing Medical Education (ACCME) and the University at Buffalo School of Medicine and Biomedical Sciences Standards for Commercial Support require that presentations are free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community.
The Editors are responsible for ensuring the content is free of commercial bias. The editor’s have no disclosures.
ACCME Standards of Commercial Support of CME require that presentations be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community. When discussing therapeutic options, faculty are requested to use only generic names. If they use a trade name, then those of several companies should be used. If a presentation includes discussion of any unlabeled or investigational use of a commercial product, faculty are required to disclose this to the participants.